Waters Corporation (NYSE:WAT) Shares Sold by Lawson Kroeker Investment Management Inc. NE

Lawson Kroeker Investment Management Inc. NE decreased its holdings in shares of Waters Corporation (NYSE:WAT - Free Report) by 12.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,502 shares of the medical instruments supplier's stock after selling 1,492 shares during the period. Lawson Kroeker Investment Management Inc. NE's holdings in Waters were worth $3,871,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd acquired a new position in shares of Waters in the 4th quarter valued at about $28,000. Steward Partners Investment Advisory LLC lifted its holdings in Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after acquiring an additional 53 shares during the last quarter. Whipplewood Advisors LLC boosted its stake in Waters by 5,200.0% in the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after acquiring an additional 104 shares during the period. Murphy & Mullick Capital Management Corp acquired a new position in Waters in the fourth quarter valued at approximately $42,000. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Waters by 54.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock valued at $46,000 after purchasing an additional 44 shares during the last quarter. Institutional investors own 94.01% of the company's stock.

Waters Price Performance

Shares of NYSE WAT traded down $5.28 during mid-day trading on Wednesday, reaching $351.76. 528,343 shares of the company traded hands, compared to its average volume of 470,710. Waters Corporation has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The firm has a market cap of $20.93 billion, a PE ratio of 31.92, a price-to-earnings-growth ratio of 3.45 and a beta of 1.10. The stock has a fifty day simple moving average of $348.28 and a 200-day simple moving average of $364.64. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.81 and a quick ratio of 1.28.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.03. The company had revenue of $661.71 million for the quarter, compared to analysts' expectations of $655.50 million. Waters had a return on equity of 41.70% and a net margin of 22.02%. The firm's revenue for the quarter was up 3.9% on a year-over-year basis. During the same period last year, the firm earned $2.21 EPS. Equities research analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Wall Street Zen downgraded Waters from a "buy" rating to a "hold" rating in a report on Saturday, June 7th. Barclays cut their target price on Waters from $400.00 to $350.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. JPMorgan Chase & Co. boosted their price target on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Robert W. Baird increased their price objective on shares of Waters from $355.00 to $374.00 and gave the stock an "outperform" rating in a report on Wednesday, May 7th. Finally, Sanford C. Bernstein set a $400.00 target price on shares of Waters and gave the company an "outperform" rating in a research note on Wednesday, April 16th. Ten analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Waters presently has a consensus rating of "Moderate Buy" and an average target price of $388.00.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.